Research and Development

Showing 15 posts of 9607 posts found.

GSK raises bid for Human Genome Services

May 9, 2012 Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …

Celgene appoints Thomas Moriarty as general counsel

May 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene, Moriarty

Celgene has appointed Thomas Moriarty as its new general counsel and corporate secretary. In this position, he will be responsible …

Pfizer releases new data for Pristiq

May 9, 2012 Research and Development, Sales and Marketing Effexor, MDD, Pfizer, Pristiq, antidepressant

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …

The joy of segmentation

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Michael Craig, marketing, segmentation

We are all different. Different heights, shapes, hair colour and we are not just different physically – what about our …

Former Novartis man becomes GSK’s new medical director

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …
Roche image

Roche abandons Phase III cholesterol drug

May 8, 2012 Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …
GSK picture

GSK signs deal with academics

May 4, 2012 Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …

GSK appoints two non-executive directors to its Board

May 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …

Oxford BioTherapeutics appoints new chief operations officer

May 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …

Professional regulation – a DIY job?

May 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …

Lilly invests in UK research base

May 2, 2012 Research and Development Elil Lilly, Erl Wood, neuroscience

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …

Targacept cuts workforce

May 1, 2012 Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …

EMA eSubmission Gateway now live

May 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …

Contract research news in brief

May 1, 2012 Research and Development BML, Cetero Labs, Covance, Harlan and Chiltern, PRA

A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …

Actelion boosted by trial success

April 30, 2012 Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …
The Gateway to Local Adoption Series

Latest content